181 related articles for article (PubMed ID: 11273186)
1. Thrombocytosis--report of a case.
Thomas M; Pavithran K; Salil ; Somarajan A
J Assoc Physicians India; 2000 Apr; 48(4):441-2. PubMed ID: 11273186
[TBL] [Abstract][Full Text] [Related]
2. Chronic myeloid leukaemia with marked thrombocytosis in a patient with thalassaemia major: complete haematological remission under the combination of hydroxyurea and anagrelide.
Voskaridou E; Terpos E; Komninaka V; Eftyhiadis E; Mantzourani M; Loukopoulos D
Br J Haematol; 2002 Jan; 116(1):155-7. PubMed ID: 11841409
[TBL] [Abstract][Full Text] [Related]
3. Severe hypersensitivity pneumonitis associated with anagrelide.
Raghavan M; Mazer MA; Brink DJ
Ann Pharmacother; 2003 Sep; 37(9):1228-31. PubMed ID: 12921504
[TBL] [Abstract][Full Text] [Related]
4. Anagrelide is effective in treating patients with hydroxyurea-resistant thrombocytosis in patients with chronic myeloid leukemia.
Silver RT
Leukemia; 2005 Jan; 19(1):39-43. PubMed ID: 15510207
[TBL] [Abstract][Full Text] [Related]
5. Anagrelide for treatment of patients with chronic myelogenous leukemia and a high platelet count.
Trapp OM; Beykirch MK; Petrides PE
Blood Cells Mol Dis; 1998 Mar; 24(1):9-13. PubMed ID: 9516377
[TBL] [Abstract][Full Text] [Related]
6. Leg ulceration with associated thrombocytosis: healing of ulceration associated with treatment of the raised platelet count.
Wirth K; Schoepf E; Mertelsmann R; Lindemann A
Br J Dermatol; 1998 Mar; 138(3):533-5. PubMed ID: 9580816
[TBL] [Abstract][Full Text] [Related]
7. Anagrelide: a new drug for treating thrombocytosis.
Silverstein MN; Petitt RM; Solberg LA; Fleming JS; Knight RC; Schacter LP
N Engl J Med; 1988 May; 318(20):1292-4. PubMed ID: 3362187
[TBL] [Abstract][Full Text] [Related]
8. Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders.
Balduini CL; Bertolino G; Noris P; Ascari E
Haematologica; 1992; 77(1):40-3. PubMed ID: 1398280
[TBL] [Abstract][Full Text] [Related]
9. Anagrelide: 20 years later.
Emadi A; Spivak JL
Expert Rev Anticancer Ther; 2009 Jan; 9(1):37-50. PubMed ID: 19105705
[TBL] [Abstract][Full Text] [Related]
10. Anagrelide, a therapy for thrombocythemic states: experience in 577 patients. Anagrelide Study Group.
Am J Med; 1992 Jan; 92(1):69-76. PubMed ID: 1731512
[TBL] [Abstract][Full Text] [Related]
11. Precipitous fall in platelet count with anagrelide: case report and critique of dosing recommendations.
McCune JS; Liles D; Lindley C
Pharmacotherapy; 1997; 17(4):822-6. PubMed ID: 9250565
[TBL] [Abstract][Full Text] [Related]
12. [Chronic myelogenous leukemia with marked thrombocytosis].
Hasegawa T; Hino M; Yamane T; Ota K; Takubo T; Kitagawa S; Tatsumi N
Rinsho Ketsueki; 2001 Mar; 42(3):199-203. PubMed ID: 11345782
[TBL] [Abstract][Full Text] [Related]
13. Platelet-lowering therapy with anagrelide as an adjuvant therapy for treatment of primary pulmonary neoplasm-associated extreme thrombocytosis.
Chen YG; Lin CS; Shen CH; Chian CF
Jpn J Clin Oncol; 2012 Aug; 42(8):761-3. PubMed ID: 22689919
[TBL] [Abstract][Full Text] [Related]
14. [Ulcers on the legs and feet: a seldom recognised side effect of hydroxyurea].
Janssen JJ; Ossenkoppele GJ
Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1517-20. PubMed ID: 12924084
[TBL] [Abstract][Full Text] [Related]
15. Essential thrombocytemia progressing to Ph+ chronic myeloid leukemia with megakaryoblastic blasts, following anagrelide withdrawal.
Piccin A; Corvetta D; Rovigatti U; Mazzoleni G; Pusceddu I; Svaldi M; Steurer M; Gastl G; Cortelazzo S
Platelets; 2014; 25(8):646-7. PubMed ID: 24205832
[No Abstract] [Full Text] [Related]
16. Thrombocytosis.
Cheung MC; Hicks LK; Pendergrast J
N Engl J Med; 2004 Jun; 350(24):2524-5; author reply 2524-5. PubMed ID: 15190151
[No Abstract] [Full Text] [Related]
17. [Anagrelide in control of myeloproliferative thrombocythemia: long-term experiences in 6 patients].
Burkhard R; Adam H; Widmer L; Honegger HP
Schweiz Med Wochenschr; 1998 Nov; 128(46):1808-12. PubMed ID: 9857387
[TBL] [Abstract][Full Text] [Related]
18. Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profile.
Steurer M; Gastl G; Jedrzejczak WW; Pytlik R; Lin W; Schlögl E; Gisslinger H
Cancer; 2004 Nov; 101(10):2239-46. PubMed ID: 15476273
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic plateletpheresis in a case of symptomatic thrombocytosis in chronic myeloid leukemia.
Thakral B; Saluja K; Malhotra P; Sharma RR; Marwaha N; Varma S
Ther Apher Dial; 2004 Dec; 8(6):497-9. PubMed ID: 15663550
[TBL] [Abstract][Full Text] [Related]
20. Role of anagrelide in the treatment of thrombocytosis.
Brooks WG; Stanley DD; Goode JV
Ann Pharmacother; 1999 Oct; 33(10):1116-8, 1121. PubMed ID: 10534225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
